4 free views remaining today
giant axonal neuropathy 1
Description
Giant Axonal Neuropathy (GAN) Description
Giant axonal neuropathy, also known as GAN, is a rare inherited genetic disorder that affects both the central and peripheral nervous systems.
- Characteristics: GAN is characterized by abnormally large and dysfunctional axons, which are the specialized extensions of nerve cells responsible for transmitting signals.
- Symptoms: The typical symptoms of GAN include clumsiness, muscle weakness, decreased muscle tone (hypotonia), and difficulty walking. As the condition progresses, individuals may experience numbness in their arms and legs, as well as slowed mental development.
Key Facts
- GAN is an inherited neurodegenerative disorder caused by mutations in the GAN gene [4].
- The condition affects both the central and peripheral nervous systems [5].
- Symptoms of GAN can range from mild to severe and may progress over time [8].
References
[1] - Giant axonal neuropathy is an inherited condition characterized by abnormally large and dysfunctional axons called giant axons. [2] - This disorder is characterized by abnormalities in the peripheral and central nervous systems including low muscle tone (hypotonia), muscle weakness, decreased ... [5] - Aug 28, 2020 — DESCRIPTION. Giant Axonal Neuropathy (GAN) is a rare inherited genetic disorder that affects both the central and peripheral nervous systems. [8] - The typical symptoms of GAN are clumsiness and muscle weakness that progresses from a “waddling gait” to a pronounced difficulty in walking. Additional symptoms ...
Additional Characteristics
- a rare inherited genetic disorder
- an inherited condition characterized by abnormally large and dysfunctional axons called giant axons
- a rare inherited neurodegenerative disorder caused by mutations in the GAN gene
- affects both the central and peripheral nervous systems
- symptoms include clumsiness, muscle weakness, decreased muscle tone (hypotonia), and difficulty walking
- numbness in their arms and legs, as well as slowed mental development
Signs and Symptoms
Giant Axonal Neuropathy (GAN) Signs and Symptoms
Giant axonal neuropathy (GAN) is a rare genetic disorder that affects the peripheral and central nervous systems. The signs and symptoms of GAN generally begin in early childhood and worsen over time.
- Early signs: Difficulty walking, lack of coordination, and loss of strength are common early signs of GAN [1][3].
- Progressive motor and sensory peripheral neuropathy: As the disorder progresses, individuals may experience difficulty with motor functions such as walking, balance, and coordination [2][4].
- Central nervous system involvement: In some cases, the central nervous system (brain and spinal cord) becomes affected, leading to symptoms such as clumsiness, muscle weakness, and cognitive impairment [5][8].
It's essential to note that the progression of GAN can vary significantly among individuals, and not everyone will experience all of these symptoms. However, early recognition and diagnosis are crucial for providing appropriate care and management.
References: [1] Jul 1, 2020 — The signs and symptoms of giant axonal neuropathy generally begin in early childhood and get worse over time. [2] This disorder is characterized by abnormalities in the peripheral and central nervous systems including low muscle tone (hypotonia), muscle weakness, decreased ... [3] Giant axonal neuropathy (GAN) is a severe, slowly progressive neurodegenerative disorder characterized by progressive motor and sensory peripheral neuropathy, ... [4] Dec 5, 2023 — You may experience difficulty walking or numbness in your arms and legs at first, but it can develop into more serious symptoms. [5] Early signs include difficulty walking, lack of coordination, and loss of strength. Over time, the central nervous system (brain and spinal cord) becomes ... [8] Most children present with delayed development and gait difficulties. ... In some, CNS signs (cerebellar, oculomotor, and upper motor neuron features) are ...
Additional Symptoms
- Cognitive impairment
- Difficulty walking
- Clumsiness
- Low muscle tone (hypotonia)
- Decreased reflexes
- Gait difficulties
- Numbness in arms and legs
- Loss of strength
- Progressive motor and sensory peripheral neuropathy
- muscle weakness
- obsolete lack of coordination
Diagnostic Tests
Giant Axonal Neuropathy (GAN) diagnosis involves several tests to confirm the condition. Here are some diagnostic tests used for GAN:
- Nerve Conduction Velocity (NCV): This test measures the speed at which electrical signals travel through nerves, helping doctors identify nerve damage.
- Brain MRI: A magnetic resonance imaging scan of the brain can help detect any abnormalities or changes in the brain associated with GAN.
- Peripheral Nerve Biopsy: In this procedure, a small sample of tissue from a peripheral nerve is removed and examined to look for swollen axons, which are characteristic of GAN.
Additionally, genetic testing is available to confirm a definitive diagnosis of GAN. This test can detect mutations in the GAN gene, which causes the condition.
It's worth noting that differential diagnoses include other conditions such as Charcot-Marie-Tooth disease (CMT-1F, -2E, -4A, -4B, -4C, -4D, and -4E), which can also present with similar symptoms. However, genetic testing can help differentiate GAN from these other conditions.
Sources:
- [1] A peripheral nerve biopsy is not sufficient to diagnose GAN due to the presence of giant axons in other diseases.
- [3] Genetic molecular testing or immunodetection of gigaxonin confirms diagnosis.
- [4] The hallmark finding on a peripheral nerve biopsy is the appearance of “giant axons” which are caused by the accumulation of neurofilaments.
- [7] The diagnosis of GAN is established by clinical findings including: Nerve conduction velocity (NCV); Lumbar puncture; Brain magnetic resonance imaging (MRI).
Additional Diagnostic Tests
- Genetic testing
- Brain MRI
- Nerve Conduction Velocity (NCV)
- Peripheral Nerve Biopsy
Treatment
Symptomatic and Supportive Treatment
Giant axonal neuropathy (GAN) has no specific treatment, but its management focuses on symptomatic relief and supportive care to improve the quality of life for affected individuals. A multidisciplinary team of healthcare professionals, including pediatric neurologists, orthopedic surgeons, physiotherapists, psychologists, and speech and language therapists, work together to provide comprehensive care.
- Physical therapy: Regular physical therapy sessions can help maintain muscle strength, mobility, and range of motion.
- Occupational therapy: Occupational therapists assist individuals with GAN in developing strategies for daily living activities, such as bathing, dressing, and feeding.
- Speech and language therapy: Speech and language therapists work with individuals to improve communication skills, including speech, language, and swallowing abilities.
- Psychological support: Psychologists provide emotional support and counseling to help individuals cope with the physical and emotional challenges of GAN.
These supportive measures can help alleviate symptoms, slow disease progression, and enhance overall well-being. However, it is essential to note that GAN is a progressive disorder, and treatment primarily focuses on managing its symptoms rather than curing the condition itself.
References:
- [2] Treatment of giant axonal neuropathy is symptomatic and supportive and often involves a team of professionals including pediatric neurologists, orthopedic surgeons, physiotherapists, psychologists and speech and language therapists.
- [6] Treatment is symptomatic, focusing on stimulating intellectual and physical development, as well as communication skills, through physical, occupational and ...
- [10] Treatment for rare childhood disease was well tolerated and slowed loss of motor function. ... known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH).
Recommended Medications
- Treatment for rare childhood disease
- treatment primarily focuses on managing its symptoms rather than curing the condition itself
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Giant Axonal Neuropathy (GAN): Differential Diagnosis
Giant Axonal Neuropathy (GAN) is a rare genetic disorder that affects the peripheral and central nervous systems. The differential diagnosis for GAN includes several conditions that present with similar symptoms.
- CMT-1F, -2E, -4A, -4B, -4C, -4D, and -4E: These are subtypes of Charcot-Marie-Tooth disease (CMT), a group of inherited disorders that affect the peripheral nerves. [1]
- Infantile Neuroaxonal Dystrophy: A rare genetic disorder characterized by progressive degeneration of the nervous system. [2]
- Arylsulfatase A Deficiency: A metabolic disorder that affects the breakdown of certain fatty substances in the body. [3]
- Spinal Muscular Atrophy: A genetic disorder that affects the nerve cells responsible for controlling voluntary muscle movement. [4]
These conditions can present with similar symptoms to GAN, such as muscle weakness, decreased reflexes, and sensory loss. However, a definitive diagnosis of GAN requires specific diagnostic tests, including:
- Nerve Conduction Studies: To assess the speed and strength of electrical signals in the nerves.
- Magnetic Resonance Imaging (MRI): To visualize the brain and spinal cord for signs of degeneration or damage.
- Immunodiagnostic Testing: To detect specific antibodies or proteins associated with GAN.
A diagnosis of GAN is typically established through a combination of clinical evaluation, laboratory tests, and genetic analysis. [5]
References:
[1] - Context 1 [2] - Context 3 [3] - Context 1 [4] - Context 1 [5] - Context 9
Additional Differential Diagnoses
- CMT-1F, -2E, -4A, -4B, -4C, -4D, and -4E
- Infantile Neuroaxonal Dystrophy
- Arylsulfatase A Deficiency
- spinal muscular atrophy
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0090068
- core#notation
- DOID:0090068
- oboInOwl#hasDbXref
- ORDO:643
- rdf-schema#label
- giant axonal neuropathy 1
- IAO_0000115
- An axonal neuopathy that is characterized by progressive motor and sensitive peripheral, central nervous system neuropathy, with axonal loss and giant axonal swellings filled with neurofilaments, and has_material_basis_in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the gigaxonin (GAN) gene on chromosome 16q23.
- rdf-schema#subClassOf
- t361837
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4281
- owl#annotatedSource
- t361657
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.